Search
Aspire Biopharma Holdings Inc
ASBPAdd to Watchlist
6.210USD
+0.350+5.97%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.04MMarket Cap
LossP/E TTM
Aspire Biopharma Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Aspire Biopharma Holdings Inc is 6.70, ranking 302 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.89, which is -20.13% below the recent high of -0.71 and -7.09% above the recent low of -0.95.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.